Eton Pharmaceuticals, Inc. Property, Plant and Equipment
Eton Pharmaceuticals, Inc. (ETON) had Property, Plant and Equipment of $352.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Net $352.00K.
- 2026-03-31: Property, Plant and Equipment, Net $372.00K.
- 2025-12-31: Property, Plant and Equipment, Net $326.00K.
- 2025-09-30: Property, Plant and Equipment, Net $294.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $352.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $372.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $326.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $294.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $18.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $22.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $34.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $33.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $45.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $57.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $58.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $38.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $46.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $56.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $72.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $73.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $87.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $72.00K 10-Q · filed 2023-05-11 | $109.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $115.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $134.00K 10-Q · filed 2021-11-16 | |
| 2021-06-30 | $156.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $176.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $811.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $854.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $938.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.02M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.12M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.17M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.22M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $773.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $268.00K 10-Q · filed 2018-12-20 | |
| 2017-12-31 | $119.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |